Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chinese hamster ovary cell (CHO) hepatitis B vaccine is considered to be the safe and effective method to prevent the hepatitis B infection. The major factor that fuels the growth of the market are increase in prevalence of hepatitis B infection worldwide. For example, approximately 887,000 deaths due to hepatitis B infection were recorded in 2015 across the globe. However, inherent disadvantages of using recombinant Chinese hamster ovary cell (CHO) to design hepatitis B vaccines restrains the growth of the market. Conversely, increase in government focus to promote (CHO) hepatitis B vaccination for adults and extensive research carried out for the same are expected to offer lucrative opportunities for the market.
The global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
Segment by Type
Pediatric Hepatitis B (CHO) Vaccine
Adult Hepatitis B (CHO) Vaccine
Segment by Application
Hospitals
Clinics
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Pediatric Hepatitis B (CHO) Vaccine
1.2.3 Adult Hepatitis B (CHO) Vaccine
1.3 麻豆原创 by Application
1.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region
2.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2019-2024)
2.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2025-2030)
2.2.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region
2.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2019-2024)
2.4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2025-2030)
2.4.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers
3.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine in 2023
3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers
3.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue in 2023
3.3 Global Key Players of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type
4.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type
4.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type
4.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2019-2024)
4.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application
5.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application
5.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application
5.3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Application (2019-2024)
5.3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Type
6.1.1 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2019-2030)
6.2 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Application
6.2.1 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2019-2030)
6.3 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Country
6.3.1 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Type
7.1.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2019-2030)
7.1.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2019-2030)
7.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Application
7.2.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2019-2030)
7.2.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2019-2030)
7.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Country
7.3.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)
7.3.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size
8.1.1 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales (2019-2030)
8.1.2 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2019-2030)
8.2 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Application
8.2.1 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2019-2030)
8.2.2 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Type
9.1.1 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2019-2030)
9.1.2 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2019-2030)
9.2 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Application
9.2.1 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2019-2030)
9.2.2 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2019-2030)
9.3 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region
9.3.1 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Region (2019-2030)
9.3.3 Asia Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Company Information
11.1.2 Merck & Co., Inc. Overview
11.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co., Inc. Recent Developments
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Information
11.2.2 GlaxoSmithKline Plc Overview
11.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Plc Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Inc. Recent Developments
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Company Information
11.4.2 Sanofi Pasteur Overview
11.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Pasteur Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Company Information
11.5.2 CSL Limited Overview
11.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL Limited Recent Developments
11.6 Emergent Biosolutions
11.6.1 Emergent Biosolutions Company Information
11.6.2 Emergent Biosolutions Overview
11.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent Biosolutions Recent Developments
11.7 Serum Institute of India
11.7.1 Serum Institute of India Company Information
11.7.2 Serum Institute of India Overview
11.7.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Serum Institute of India Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson & Johnson Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Chain Analysis
12.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Mode & Process
12.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales and 麻豆原创ing
12.4.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Sales Channels
12.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors
12.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers
13 麻豆原创 Dynamics
13.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industry Trends
13.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Drivers
13.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Challenges
13.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine 麻豆原创 Restraints
14 Key Findings in The Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Merck & Co., Inc.
GlaxoSmithKline Plc
Pfizer Inc.
Sanofi Pasteur
CSL Limited
Emergent Biosolutions
Serum Institute of India
Johnson & Johnson
听
听
*If Applicable.